Table I.
Characteristic | Adult, n=31 | Children/adolescent, n=28 |
---|---|---|
Age, yearsa | 47.4±14.1 | 11.0±5.1 |
Age range, years | 23-70 | 2-21 |
Male, n (%) | 12(39) | 17(61) |
Female, n (%) | 19(61) | 11(39) |
Family history, n (%) | 23(74) | 24(86) |
Maximal total cholesterol, mmol/la | 11.0±2.2 | 9.3±1.4 |
LDL cholesterol, mmol/la | 6.8±2.5 | 6.7±1.8 |
Tendon xanthomas, n (%) | 22(71) | 0 (0) |
Lipoic corneal arcus, n (%) | 2(6) | 0 (0) |
Clinical and instrumental manifestations of ASCVD, n (%) | 17(55) | 0 (0) |
Increased intima-media thickness without clinical symptoms, n (%) | 3(10) | 0 (0) |
Patients on lipid-lowering therapy, n (%) | 31(100) | 1(4) |
aMean ± standard deviation. ASCVD, atherosclerotic cardiovascular disease; LDL, low density lipoprotein.